DIAGNOSTIC TEST

PCT No. PCT/GB91/02228 Sec. 371 Date Aug. 30, 1993 Sec. 102(e) Date Aug. 30, 1993 PCT Filed Dec. 13, 1991 PCT Pub. No. WO92/10759 PCT Pub. Date Jun. 25, 1992.A diagnostic test can determine the occurrence of myocardial infarction or the total plasma antioxidant status as a marker of predisposition t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	RICE-EVANS, CATHERINE, ANNE, DAVIES, MICHAEL JONATHAN
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES DIAGNOSIS ENZYMOLOGY HUMAN NECESSITIES HYGIENE IDENTIFICATION INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS SURGERY TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PCT No. PCT/GB91/02228 Sec. 371 Date Aug. 30, 1993 Sec. 102(e) Date Aug. 30, 1993 PCT Filed Dec. 13, 1991 PCT Pub. No. WO92/10759 PCT Pub. Date Jun. 25, 1992.A diagnostic test can determine the occurrence of myocardial infarction or the total plasma antioxidant status as a marker of predisposition to such an event, or the antioxidant status of other clinical and non-clinical samples. The test involves contacting a clinical sample in the presence of myoglobin and an oxidant therefor with a compound which reacts in that environment to form a chromogenic species with a characteristic absorption band in the visible spectrum spaced from potentially interfering bands attributable to haem proteins and other blood components.